JOSE CONCEPCION
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology SAN JUAN, PR NPI 1699183129
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology PR E.R. Squibb & Sons, L.L.C. All categories
General Payments — all program years on this page
$12,627.48
- Category: General Payments
- Program years: PY2018–2024
- Record count: 309
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,720.08 across 72 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,521.13 | 70 |
| Education | $198.95 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $330.74 | 6 |
| SOBI, INC | $303.37 | 5 |
| Tempus AI, Inc | $236.31 | 9 |
| Adaptive Biotechnologies Corporation | $171.81 | 1 |
| ABBVIE INC. | $150.00 | 2 |
| EISAI INC. | $148.83 | 2 |
| Rigel Pharmaceuticals, Inc. | $144.92 | 2 |
| Amgen Inc. | $135.60 | 6 |
| Lilly USA, LLC | $118.71 | 1 |
| Astellas Pharma US Inc | $116.45 | 2 |
| PBG PUERTO RICO LLC | $111.61 | 5 |
| Genmab U.S., Inc. | $109.86 | 1 |
| Janssen Pharmaceuticals, Inc | $90.93 | 4 |
| Merck Sharp & Dohme Corporation | $86.97 | 4 |
| Acerta Pharma LLC | $75.05 | 4 |
| Eli Lilly Export S.A. Puerto Rico Branch | $60.00 | 3 |
| Genentech USA, Inc. | $41.34 | 2 |
| PFIZER INC. | $40.40 | 2 |
| SpringWorks Therapeutics, Inc. | $38.61 | 2 |
| Exelixis Inc. | $28.89 | 1 |
| Regeneron Healthcare Solutions, Inc. | $26.66 | 1 |
| TAIHO ONCOLOGY, INC. | $24.53 | 1 |
| BeiGene USA, Inc. | $24.53 | 1 |
| AVEO Pharmaceuticals, Inc. | $23.70 | 1 |
| Bayer Puerto Rico Inc. | $22.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.18 | 1 |
| Blueprint Medicines Corporation | $20.07 | 1 |
| GlaxoSmithKline, LLC. | $17.01 | 1 |
By program year
Records — PY2024 (72)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.